New York Losartan Lawyer
Fighting for Injured Blood Pressure Patients
Millions of Americans take blood pressure medications every day, many of which contain angiotensin II receptor blockers (ARBs) like losartan. Unfortunately, in November 2018, the FDA issued a voluntary recall for dozens of batches of losartan and related medications, after discovering the presence of a possible human carcinogen known as N-nitrosodimethylamine (NDMA). An investigation later revealed that overseas drug manufacturers were behind the NDMA contamination.
At Rheingold Giuffra Ruffo & Plotkin LLP, our experienced New York losartan injury lawyers can help you seek compensation if you’ve suffered injuries after using losartan. We’ve recovered over $2 billion in damages for injury victims across New York, and as dangerous drug litigators, we know exactly how to create a winning case strategy for these claims.
For more information about our legal services, call (888) 260-0473 and speak with one of our experienced trial attorneys.
Who Manufactures Losartan?
Losartan is a drug compound that can be used on its own to regulate blood pressure – but more commonly, it is combined with other compounds to create new medications. Much like valsartan and irbesartan, losartan has a generic brand name: Cozaar. Although the brand name product expired back in 2010, there are still dozens of generic losartan versions sold in the United States. Many of these rely on losartan compounds produced at Zhejiang Huahai Pharmaceuticals and Hetero Labs: Two overseas losartan manufacturers that had contaminated batches with NDMA.
Here are some of the biggest manufacturers for losartan-based drugs:
Side Effects of Using Contaminated Losartan
Losartan already comes with a range of risks and side effects, including vertigo, abdominal pain, upper respiratory infection, and constipation. When a batch of losartan has been contaminated with NDMA, however, the potential side effects can be catastrophic. This is because NDMA has been proven to cause cancer in lab rats, and is classified as a probable human carcinogen by both the FDA and the European Medicines Agency.
NDMA and similar contaminants can cause the following forms of cancer:
Taking Action Against Negligent Pharmaceutical Producers
The FDA has already issued dozens of recalls for products containing losartan, valsartan, and irbesartan, in an attempt to protect the public from further injury. However, public health advocates believe that the NDMA contamination may have been present in some lots for up to 4 years. When taken consistently as part of a blood pressure regulation routine, these medications may cause cancer in multiple forms.
If you believe that your cancer diagnosis or liver damage was directly related to taking losartan, contact Rheingold Giuffra Ruffo & Plotkin LLP. We fight relentlessly to secure positive results for our clients – and with countless awards and successful case settlements won, we have the experience to increase your chances of compensation.
Call (888) 260-0473 to get your free case evaluation.